STUDY VALIDATES BREVAGen MORE ACCURATELY IDENTIFIES BREAST CANCER RISK LEADING TO INCREASED BREAST HEALTH COMPLIANCE
15. April 2013 12:06 ET
|
Genetic Technologies Group
CHARLOTTE, N.C., April 15, 2013 (GLOBE NEWSWIRE) -- Phenogen Sciences, Inc. recently presented study results demonstrating that BREVAGen™, a first-in-class, scientifically-validated predictive...